Cargando…
Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COV...
Autores principales: | Babu, Tara M., Wald, Anna, Restar, Arjee J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303319/ https://www.ncbi.nlm.nih.gov/pubmed/37391114 http://dx.doi.org/10.1016/j.annepidem.2023.06.024 |
Ejemplares similares
-
Methodological Critique of Littman’s (2018) Parental-Respondents Accounts of “Rapid-Onset Gender Dysphoria”
por: Restar, Arjee Javellana
Publicado: (2019) -
Promoting gender equity and inclusion through allyship
por: Ayyala, Rama S., et al.
Publicado: (2022) -
Gender-affirming care is preventative care
por: Restar, Arjee Javellana
Publicado: (2023) -
Strategies to improve diversity, equity, and inclusion in clinical trials
por: Kahn, Justine M., et al.
Publicado: (2021) -
Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research
por: Broadwin, Cassandra, et al.
Publicado: (2023)